These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29237930)

  • 1. Effects of Prior Antiplatelet Therapy on the Prognosis of Primary Intracerebral Hemorrhage: A Meta-analysis.
    Yu HH; Pan C; Tang YX; Liu N; Zhang P; Hu Y; Zhang Y; Wu Q; Deng H; Li GG; Li YY; Nie H; Tang ZP
    Chin Med J (Engl); 2017 Dec; 130(24):2969-2977. PubMed ID: 29237930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis.
    Camps-Renom P; Alejaldre-Monforte A; Delgado-Mederos R; Martínez-Domeño A; Prats-Sánchez L; Pascual-Goñi E; Martí-Fàbregas J
    Eur J Neurol; 2017 Feb; 24(2):302-308. PubMed ID: 27801531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Prior Antiplatelet Therapy on Mortality, Functional Outcome, and Hematoma Expansion in Intracerebral Hemorrhage: An Updated Systematic Review and Meta-Analysis of Cohort Studies.
    Wu Y; Zhang D; Chen H; Liu B; Zhou C
    Front Neurol; 2021; 12():691357. PubMed ID: 34497575
    [No Abstract]   [Full Text] [Related]  

  • 4. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review.
    Thompson BB; Béjot Y; Caso V; Castillo J; Christensen H; Flaherty ML; Foerch C; Ghandehari K; Giroud M; Greenberg SM; Hallevi H; Hemphill JC; Heuschmann P; Juvela S; Kimura K; Myint PK; Nagakane Y; Naritomi H; Passero S; Rodríguez-Yáñez MR; Roquer J; Rosand J; Rost NS; Saloheimo P; Salomaa V; Sivenius J; Sorimachi T; Togha M; Toyoda K; Turaj W; Vemmos KN; Wolfe CD; Woo D; Smith EE
    Neurology; 2010 Oct; 75(15):1333-42. PubMed ID: 20826714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage.
    Li Y; Liu X; Chen S; Wang J; Pan C; Li G; Tang Z
    CNS Neurosci Ther; 2023 Jun; 29(6):1484-1496. PubMed ID: 36942509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage.
    van Ginneken V; Engel P; Fiebach JB; Audebert HJ; Nolte CH; Rocco A
    Neurol Sci; 2018 Apr; 39(4):745-748. PubMed ID: 29441487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage.
    Creutzfeldt CJ; Weinstein JR; Longstreth WT; Becker KJ; McPharlin TO; Tirschwell DL
    J Stroke Cerebrovasc Dis; 2009; 18(3):221-8. PubMed ID: 19426894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage.
    Sprügel MI; Kuramatsu JB; Gerner ST; Sembill JA; Beuscher VD; Hagen M; Roeder SS; Lücking H; Struffert T; Dörfler A; Schwab S; Huttner HB
    Stroke; 2018 Nov; 49(11):2621-2629. PubMed ID: 30355188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Previous Use of Antiplatelet Therapy and Intracerebral Hemorrhage Outcomes.
    Khan NI; Siddiqui FM; Goldstein JN; Cox M; Xian Y; Matsouaka RA; Heidenreich PA; Peterson ED; Bhatt DL; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2017 Jul; 48(7):1810-1817. PubMed ID: 28596454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia and Clinical Outcomes in Intracerebral Hemorrhage: A Retrospective Multicenter Cohort Study.
    Mrochen A; Sprügel MI; Gerner ST; Sembill JA; Lang S; Lücking H; Kuramatsu JB; Huttner HB
    Stroke; 2021 Jan; 52(2):611-619. PubMed ID: 33430632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of platelet transfusion on functional independence and mortality after antiplatelet therapy associated spontaneous intracerebral hemorrhage: A systematic review and meta-analysis.
    Morris NA; Patel N; Galvagno SM; Ludeman E; Schwartzbauer GT; Pourmand A; Tran QK
    J Neurol Sci; 2020 Oct; 417():117075. PubMed ID: 32763508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior Antiplatelet Therapy, Excluding Phosphodiesterase Inhibitor Is Associated with Poor Outcome in Patients with Spontaneous Intracerebral Haemorrhage.
    Liu ZH; Liu CH; Tu PH; Yip PK; Chen CC; Wang YC; Chen NY; Lin YS
    Transl Stroke Res; 2020 Apr; 11(2):185-194. PubMed ID: 31446619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
    Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
    Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of restarting antiplatelet therapy in patients with intracerebral hemorrhage.
    Jung NY; Cho J
    Clin Neurol Neurosurg; 2022 Sep; 220():107361. PubMed ID: 35835024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Platelet Transfusion on Intracerebral Hemorrhage in Patients on Antiplatelet Therapy-An Analysis Based on Intracerebral Hemorrhage Score.
    Arnone GD; Kumar P; Wonais MC; Esfahani DR; Campbell-Lee SA; Charbel FT; Amin-Hanjani S; Alaraj A; Seicean A; Mehta AI
    World Neurosurg; 2018 Mar; 111():e895-e904. PubMed ID: 29330079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Antiplatelet Use on the Risk of Intracerebral Hemorrhage in Patients with Alzheimer's Disease: A Nationwide Cohort Study.
    Lee TL; Liu CH; Chang YM; Lin TY; Chien CY; Chen CH; Tsai KJ; Lin SH; Sung PS
    J Alzheimers Dis; 2020; 73(1):297-306. PubMed ID: 31771060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in traumatic brain injury for patients presenting on antiplatelet therapy.
    Cull JD; Sakai LM; Sabir I; Johnson B; Tully A; Nagy K; Dennis A; Starr FL; Joseph K; Wiley D; Moore HR; Oliphant UJ; Bokhari F
    Am Surg; 2015 Feb; 81(2):128-32. PubMed ID: 25642873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
    Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
    JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy may improve the prognosis of patients with moyamoya disease: a 12-year retrospective study.
    Luo Y; Cao Z; Ye H; Wu S; Sun X
    J Neurol; 2023 Aug; 270(8):3876-3884. PubMed ID: 37106259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusion for spontaneous intracerebral hemorrhage with prior antiplatelet: A systematic review and meta-analysis.
    Lin Y; Liu Y; Liu L; Zhang L; Lin Y; Yu J; Yang J
    Medicine (Baltimore); 2023 Nov; 102(46):e36072. PubMed ID: 37986382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.